Literature DB >> 15838873

Membrane localization of all class I PI 3-kinase isoforms suppresses c-Myc-induced apoptosis in Rat1 fibroblasts via Akt.

Wolfgang Link1, Aranzazu Rosado, Jesus Fominaya, James E Thomas, Amancio Carnero.   

Abstract

Phosphoinositide 3'-kinases (PI3Ks) constitute a family of lipid kinases implicated in signal transduction through tyrosine kinase receptors and heterotrimeric G protein-linked receptors. PI3Ks are heterodimers made up of four different 110-kDa catalytic subunits (p110alpha, p110beta, p110gamma, and p110delta) and a smaller regulatory subunit. Despite a clear implication of PI3Ks in survival signaling, the contribution of the individual PI3K isoforms has not been elucidated. To address this issue, we generated Rat1 fibroblasts that co-express c-Myc and membrane targeted derivates of the different p110 isoforms. Here we present data for the first time showing that activation of PI3-kinase signaling through membrane localization of p110beta, p110gamma, and p110delta protects c-Myc overexpressing Rat1 fibroblasts from apoptosis caused by serum deprivation like it has been described for p110alpha. Expression of each p110 isoform reduces significantly caspase-3 like activity in this apoptosis model. Decreased caspase-3 activity correlates with the increase in Akt phosphorylation in cells that contain one of the myristoylated p110 isoforms. p110 isoform-mediated protection from cell death was abrogated upon expression of a kinase-negative version of Akt. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838873     DOI: 10.1002/jcb.20479

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

1.  Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Authors:  Sohye Kang; Adam Denley; Bart Vanhaesebroeck; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.

Authors:  Yue-Zu Fan; Wei Sun
Journal:  World J Gastrointest Surg       Date:  2010-04-27

3.  Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival.

Authors:  Matthias Drosten; Alma Dhawahir; Eleanor Y M Sum; Jelena Urosevic; Carmen G Lechuga; Luis M Esteban; Esther Castellano; Carmen Guerra; Eugenio Santos; Mariano Barbacid
Journal:  EMBO J       Date:  2010-02-11       Impact factor: 11.598

Review 4.  Inhibiting PI3K as a therapeutic strategy against cancer.

Authors:  Luis Paz-Ares; Carmen Blanco-Aparicio; Rocío García-Carbonero; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

5.  Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.

Authors:  Carmen Blanco-Aparicio; Marta Cañamero; Yolanda Cecilia; Belén Pequeño; Oliver Renner; Irene Ferrer; Amancio Carnero
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

Review 6.  Genetic modelling of the PTEN/AKT pathway in cancer research.

Authors:  Oliver Renner; Carmen Blanco-Aparicio; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2008-10       Impact factor: 3.405

7.  In vivo expression of signaling proteins in reconstituted NK cells.

Authors:  Selinda J Orr; Laura Quigley; Daniel W McVicar
Journal:  J Immunol Methods       Date:  2008-11-24       Impact factor: 2.303

8.  Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era.

Authors:  Christine Carico; Miriam Nuño; Debraj Mukherjee; Adam Elramsisy; Jocelynn Dantis; Jethro Hu; Jeremy Rudnick; John S Yu; Keith L Black; Serguei I Bannykh; Chirag G Patil
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

9.  Mutations in PIK3CA are infrequent in neuroblastoma.

Authors:  Vincent Dam; Brian T Morgan; Pavel Mazanek; Michael D Hogarty
Journal:  BMC Cancer       Date:  2006-07-05       Impact factor: 4.430

10.  A dual-color fluorescence-based platform to identify selective inhibitors of Akt signaling.

Authors:  Aranzazú Rosado; Fabian Zanella; Beatriz Garcia; Amancio Carnero; Wolfgang Link
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.